Somerville Kurt F Eli Lilly & CO Transaction History

Somerville Kurt F

$606 Million
Q3 2024

A detailed history of Somerville Kurt F transactions in Eli Lilly & CO stock. As of the latest transaction made, Somerville Kurt F holds 3,822 shares of LLY stock, worth $2.87 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares

3,822

Previous 3,950 3.24%

Holding current value

$2.87 Million

Previous $3.58 Million 5.31%

% of portfolio

0.56%

Previous 0.61%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$772.14 - $960.02 $98,833 - $122,882	-128 Reduced 3.24%	3,822 $3.39 Million
Q2 2024 Aug 12, 2024	SELL	$724.87 - $909.04 $224,709 - $281,802	-310 Reduced 7.28%	3,950 $3.58 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $227,997 - $305,027	-385 Reduced 8.29%	4,260 $3.31 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $102,937 - $121,349	-196 Reduced 4.05%	4,645 $2.71 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $76,072 - $104,877	-175 Reduced 3.49%	4,841 $2.6 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $57,872 - $77,381	-165 Reduced 3.18%	5,016 $2.35 Million
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $91,635 - $107,621	-295 Reduced 5.39%	5,181 $1.78 Million
Q4 2022 Feb 09, 2023	SELL	$321.55 - $374.67 $16,077 - $18,733	-50 Reduced 0.9%	5,476 $2 Million
Q3 2022 Nov 08, 2022	SELL	$296.48 - $337.87 $1,482 - $1,689	-5 Reduced 0.09%	5,526 $1.79 Million
Q2 2022 Jul 19, 2022	SELL	$278.73 - $327.27 $45,711 - $53,672	-164 Reduced 2.88%	5,531 $1.79 Million
Q1 2022 May 17, 2022	SELL	$234.69 - $291.66 $26,989 - $33,540	-115 Reduced 1.98%	5,695 $1.63 Million
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $12,366 - $15,347	55 Added 0.96%	5,810 $1.61 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $67,588 - $83,176	-305 Reduced 5.03%	5,755 $1.33 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $32,864 - $42,544	-200 Reduced 3.19%	6,060 $1.13 Million
Q3 2020 Oct 28, 2020	SELL	$146.22 - $169.13 $25,588 - $29,597	-175 Reduced 2.72%	6,260 $927,000
Q2 2020 Jul 28, 2020	SELL	$136.42 - $164.18 $15,688 - $18,880	-115 Reduced 1.76%	6,435 $1.06 Million
Q1 2020 May 07, 2020	BUY	$119.05 - $147.35 $132,145 - $163,558	1,110 Added 20.4%	6,550 $909,000
Q4 2019 Jan 15, 2020	SELL	$106.92 - $132.43 $5,346 - $6,621	-50 Reduced 0.91%	5,440 $715,000
Q3 2019 Nov 06, 2019	SELL	$106.79 - $116.16 $2,669 - $2,904	-25 Reduced 0.45%	5,490 $614,000
Q2 2019 Jul 24, 2019	SELL	$110.79 - $129.32 $40,438 - $47,201	-365 Reduced 6.21%	5,515 $611,000
Q1 2019 May 01, 2019	SELL	$111.31 - $131.02 $30,610 - $36,030	-275 Reduced 4.47%	5,880 $763,000
Q3 2018 Oct 15, 2018	SELL	$85.86 - $107.31 $27,904 - $34,875	-325 Reduced 5.02%	6,155 $661,000
Q2 2018 Jul 30, 2018	SELL	$75.7 - $86.88 $7,570 - $8,688	-100 Reduced 1.52%	6,480 $553,000
Q1 2018 Apr 24, 2018	SELL	$74.21 - $87.6 $47,939 - $56,589	-646 Reduced 8.94%	6,580 $509,000
Q4 2017 Feb 02, 2018	SELL	$81.94 - $87.89 $19,665 - $21,093	-240 Reduced 3.21%	7,226 $610,000
Q3 2017 Oct 26, 2017	BUY	$77.07 - $85.54 $575,404 - $638,641	7,466	7,466 $639,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Somerville Kurt F, based on Form 13F filings with the SEC.

News

Stay updated on Somerville Kurt F with notifications on news.

Account

Somerville Kurt F Eli Lilly & CO Transaction History